(Q28276986)

English

Preliminary evidence of attenuation of the disruptive effects of the NMDA glutamate receptor antagonist, ketamine, on working memory by pretreatment with the group II metabotropic glutamate receptor agonist, LY354740, in healthy human subjects

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

0 references

Preliminary evidence of attenuation of the disruptive effects of the NMDA glutamate receptor antagonist, ketamine, on working memory by pretreatment with the group II metabotropic glutamate receptor agonist, LY354740, in healthy human subjects (English)

0 references

human subject research project

0 references

object named as

Aysenil Belger

9

0 references

Ralitza Gueorguieva

object named as

Ralitza Gueorguieva

6

0 references

1

object named as

John H Krystal

0 references

author name string

Walid Abi-Saab

2

0 references

Edward Perry

3

0 references

D Cyril D'Souza

4

0 references

Nianjin Liu

5

0 references

Lisa McDougall

7

0 references

Tracy Hunsberger

8

0 references

Louise Levine

10

0 references

Alan Breier

11

0 references

language of work or name

0 references

publication date

April 2005

0 references

Psychopharmacology

0 references

179

0 references

1

0 references

303-9

0 references

Association of ketamine-induced psychosis with focal activation of the prefrontal cortex in healthy volunteers

1 reference

https://api.crossref.org/works/10.1007%2FS00213-004-1982-8

21 January 2018

PHARMACOLOGIC EFFECTS OF CI-581, A NEW DISSOCIATIVE ANESTHETIC, IN MAN.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-004-1982-8

21 January 2018

Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses

1 reference

https://api.crossref.org/works/10.1007%2FS00213-004-1982-8

21 January 2018

The metabotropic glutamate 2/3 receptor agonists LY354740 and LY379268 selectively attenuate phencyclidine versus d-amphetamine motor behaviors in rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/15309376

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A role for NMDA-receptor channels in working memory.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15309376

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ketamine increases human motor cortex excitability to transcranial magnetic stimulation

1 reference

https://pubmed.ncbi.nlm.nih.gov/15309376

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development

1 reference

https://pubmed.ncbi.nlm.nih.gov/15309376

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Subsynaptic segregation of metabotropic and ionotropic glutamate receptors as revealed by immunogold localization

1 reference

https://pubmed.ncbi.nlm.nih.gov/15309376

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Positive and Negative Syndrome Scale (PANSS): rationale and standardisation

1 reference

https://pubmed.ncbi.nlm.nih.gov/15309376

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/15309376

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

NMDA-dependent modulation of CA1 local circuit inhibition.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15309376

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex

1 reference

https://pubmed.ncbi.nlm.nih.gov/15309376

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

NMDA agonists and antagonists as probes of glutamatergic dysfunction and pharmacotherapies in neuropsychiatric disorders

1 reference

https://pubmed.ncbi.nlm.nih.gov/15309376

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Psychosis: pathological activation of limbic thalamocortical circuits by psychomimetics and schizophrenia?

1 reference

https://pubmed.ncbi.nlm.nih.gov/15309376

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ketamine activates psychosis and alters limbic blood flow in schizophrenia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15309376

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

NMDA receptor function and human cognition: the effects of ketamine in healthy volunteers

1 reference

https://pubmed.ncbi.nlm.nih.gov/15309376

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The arrangement of glutamate receptors in excitatory synapses

1 reference

https://pubmed.ncbi.nlm.nih.gov/15309376

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Unveiling the functions of presynaptic metabotropic glutamate receptors in the central nervous system

1 reference

https://pubmed.ncbi.nlm.nih.gov/15309376

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ketamine-induced NMDA receptor hypofunction as a model of memory impairment and psychosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/15309376

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lack of effect of LY314582 (a group 2 metabotropic glutamate receptor agonist) on phencyclidine-induced locomotor activity in metabotropic glutamate receptor 2 knockout mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/15309376

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dissociation of mnemonic and perceptual processes during spatial and nonspatial working memory using fMRI.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15309376

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

NMDA receptor regulation of memory and behavior in humans

1 reference

https://pubmed.ncbi.nlm.nih.gov/15309376

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Attenuation of ketamine effects by nimodipine pretreatment in recovering ethanol dependent men: psychopharmacologic implications of the interaction of NMDA and L-type calcium channel antagonists

1 reference

https://pubmed.ncbi.nlm.nih.gov/15309376

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Five-component model of schizophrenia: Assessing the factorial invariance of the positive and negative syndrome scale

1 reference

https://pubmed.ncbi.nlm.nih.gov/15309376

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lamotrigine prevents ketamine but not amphetamine-induced deficits in prepulse inhibition in mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/15309376

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Control of feedforward dendritic inhibition by NMDA receptor-dependent spike timing in hippocampal interneurons.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15309376

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Measurement of visual sustained attention in schizophrenia using signal detection analysis and a newly developed computerized CPT task

1 reference

https://pubmed.ncbi.nlm.nih.gov/15309376

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neuroleptics improve sustained attention in schizophrenia. A study using signal detection theory

1 reference

https://pubmed.ncbi.nlm.nih.gov/15309376

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Differential psychopathology and patterns of cerebral glucose utilisation produced by (S)- and (R)-ketamine in healthy volunteers using positron emission tomography (PET)

1 reference

https://pubmed.ncbi.nlm.nih.gov/15309376

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

NMDA receptor hypofunction model of schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/15309376

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interactive effects of subanesthetic ketamine and subhypnotic lorazepam in humans

1 reference

https://pubmed.ncbi.nlm.nih.gov/15309376

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacology and functions of metabotropic glutamate receptors

1 reference

https://pubmed.ncbi.nlm.nih.gov/15309376

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Synaptic basis of cortical persistent activity: the importance of NMDA receptors to working memory.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15309376

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anxiolytic and side-effect profile of LY354740: a potent, highly selective, orally active agonist for group II metabotropic glutamate receptors

1 reference

https://pubmed.ncbi.nlm.nih.gov/15309376

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacological agents acting at subtypes of metabotropic glutamate receptors

1 reference

https://pubmed.ncbi.nlm.nih.gov/15309376

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of ketamine on sensory perception: evidence for a role of N-methyl-D-aspartate receptors

1 reference

https://pubmed.ncbi.nlm.nih.gov/15309376

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Involvement of gamma-aminobutyric acid neurotransmission in phencyclidine-induced dopamine release in the medial prefrontal cortex

1 reference

https://pubmed.ncbi.nlm.nih.gov/15309376

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

LY354740, an mGlu2/3 receptor agonist as a novel approach to treat anxiety/stress

1 reference

https://pubmed.ncbi.nlm.nih.gov/15309376

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Attenuation of the neuropsychiatric effects of ketamine with lamotrigine: support for hyperglutamatergic effects of N-methyl-D-aspartate receptor antagonists.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15309376

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00213-004-1982-8

0 references

Dimensions Publication ID

0 references

PubMed publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28276986&oldid=2177580200"